Your browser doesn't support javascript.
loading
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study.
Sarantopoulos, John; Mita, Alain C; He, Aiwu; Wade, James L; Hsueh, Chung-Tsen; Morris, John C; Lockhart, A Craig; Quinn, David I; Hwang, Jimmy; Mier, James; Zhang, Wenping; Wack, Claudine; Yin, Jian; Clot, Pierre-François; Rixe, Olivier.
Afiliação
  • Sarantopoulos J; Institute for Drug Development, Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Mita AC; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • He A; Department of Medicine and Oncology and Innovation Center for Biomedical Informatics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Wade JL; Division of Medical Oncology/Hematology, Cancer Care Center of Decatur, Decatur, IL, USA.
  • Hsueh CT; Division of Medical Oncology/Hematology, Loma Linda University, Loma Linda, CA, USA.
  • Morris JC; Division of Hematology-Oncology, Department of Medicine, University of Cincinnati Cancer Institute, Cincinnati, OH, USA.
  • Lockhart AC; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Quinn DI; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Hwang J; Department of Medicine and Oncology and Innovation Center for Biomedical Informatics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Mier J; Department of Medicine, Dana-Farber/Harvard Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Zhang W; Sanofi, Bridgewater, NJ, USA.
  • Wack C; Sanofi, Chilly-Mazarin, France.
  • Yin J; Sanofi, Bridgewater, NJ, USA.
  • Clot PF; Sanofi, Chilly-Mazarin, France.
  • Rixe O; Division of Hematology/Oncology, Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA. ORixe@salud.unm.edu.
Cancer Chemother Pharmacol ; 79(2): 339-351, 2017 Feb.
Article em En | MEDLINE | ID: mdl-28058445
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Falência Hepática / Taxoides / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Falência Hepática / Taxoides / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha